GENE ONLINE|News &
Opinion
Blog

2022-05-16| Special

Financial Times’ US Pharma Biotech Summit 2022: Track & Invest in American Life Sciences

by Sahana Shankar
Share To
healthcare and driving forces of the biotech industry of the future and its shaping of public health infrastructure.  

In a discussion panel titled “Navigating the American life sciences investment landscape”, thought leaders in healthcare investment shared their views on how the biotech market is fast growing and the challenges in raising capital from different avenues. Moderated by Sujeet Indap, US Lex Editor, Financial Times, the panelists included: 

  • David Lee, CEO, Servier Pharmaceuticals
  • Karen Snow, Senior VP, Head of US Listings and Revenue, Nasdaq
  • Steven Zachary, Managing Partner, Sands Capital

 

It's free! Log in now to read

LATEST
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scientists Identified Potential New Drugs to Combat Blindness
2023-05-21
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
EVENT
2023-05-16
The 2nd International Healthcare Week
Hong Kong , China
2023-06-02
2023 ASCO annual meeting
Chicago, USA
2023-07-26
BIO Asia-Taiwan 2023
Taipei, Taiwan
2023-09-06
2023 Bio Asia Pacific
Bangkok, Thailand
Scroll to Top